Halis Akturk is an Endocrinology/Metabolic physician affiliated with University of Colorado Anschutz Medical Campus. OpenAlex indexes 201 publications with 3,954 citations (h-index 34); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1775 Aurora Ct
Mail Stop A140
Aurora, CO 800452536
Telephone
303-724-0467Registry record last updated 26 Jan 2017.
Clinical trials
- Evaluation of the MiniMed™ 780G System in Type 1 Adult and Pediatric Subjects Utilizing Insulin Fiasp®
Sponsor: Medtronic MiniMed, Inc.
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
17 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- F. Hoffmann-La Roche AGProgram year20258 payments$14,115openpaymentsdata.cms.gov ↗
- Dexcom, Inc.Program year20259 payments$12,284openpaymentsdata.cms.gov ↗
- Medtronic, Inc.Program year202512 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
62.7%Insulin Analog40.1%Humalog Kwikpen U-10029%Humalog22%Lantus Solostar22%Tresiba Flextouch U-10013%Toujeo Solostar7%Novolog Flexpen7%Part D<11 patientsGLP-1 receptor agonist14.7%Mounjaro55%Ozempic45%Part D<11 patients+ 2 more classes in this area
Cardiovascular
24.7%Statin11.9%Atorvastatin Calcium100%Part D≥16 patientsAngiotensin receptor blocker (ARB)6.2%Losartan Potassium100%Part D<11 patients+ 2 more classes in this area
Hormonal (systemic)
12.6%l-Thyroxine12.6%Levothyroxine Sodium80%Synthroid20%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Effectiveness of Semaglutide and Tirzepatide in Overweight and Obese Adults with Type 1 Diabetes
Diabetes Technology & Therapeutics
2025 - Efficacy and Safety of Tirzepatide in Overweight and Obese Adult Patients with Type 1 Diabetes
Diabetes Technology & Therapeutics
2024 - Efficacy and Safety of Tirzepatide in Adults With Type 1 Diabetes: A Proof of Concept Observational Study
Journal of Diabetes Science and Technology
2024 - The Diabetes Technology Society Error Grid and Trend Accuracy Matrix for Glucose Monitors
Journal of Diabetes Science and Technology
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Richard Schulick, MD, MBA
University of Colorado Anschutz Medical Campus
John Rumsfeld, MD, PhD
University of Colorado Anschutz Medical Campus
Robert Eckel, MD
University of Colorado Anschutz Medical Campus
Marc Bonaca, MD
University of Colorado Anschutz Medical Campus
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”